A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung Cancer
Withdrawn before enrolling
Conditions studied: NSCLC, Non Small Cell Lung Cancer
In brief
For patients diagnosed with early (Stage I) non-small cell lung cancer, a lobe of lung is usually removed at surgery to treat the cancer. For some patients, the removal of a lobe of lung may leave too little lung behind for easy breathing. For some of these patients, it may be possible to perform a smaller-scale surgery ("sub-lobar resection") and place a radioactive implant behind to prevent the cancer from growing back. This study will see how these patients do in terms of controlling their disease treated with a radioactive implant called Cesium-131.
Key facts
- Study ID
- NCT01237171
- Run by
- IsoRay Medical, Inc.
- People needed
- 0
- Starts
- 2010-11-01
- Expected to finish
- 2010-11-01
- Last updated by the study team
- 2021-03-30
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients must have suspicious lung nodule for clinical stage I/recurrent non-small cell Lung Cancer
- Mass Tumor size < 7 cm
- Patient must have a CT scan of the chest with upper abdomen within 90 days prior to date of pre-registration.
- Patient must have ECOG/Zubrod performance status 0,1, or 2.
You may not qualify if…
- Patient has already received high dose radiation to the area
- Cancerous nodule is very close to the esophagus or spinal cord, thereby increasing the risk of radiation treatment
- Pregnancy or unwillingness to practice a form of birth control (i.e. abstinence, oral contraceptives, etc.)
Where it is running
- Weill Cornell Medical College — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.